Our proteomics analysis revealed that clusterin was increased by 1.37-fold in frontal cortex synapses in PSP, which is of interest as clusterin gene variants are associated with AD risk, and our previous data implicate clusterin in amyloid β-mediated synapse loss in AD33. Here, CLU is linked to Alzheimer disease.